• Icade's first Green Bond

     |  Paris

    90045cae9e33-c547-4c19-b51e-a5ca9c5b8397

    Icade's first Green Bond

    Icade's first Green Bond

    Olivier Wigniolle, CEO of Icade, and Victoire Aubry, CFO, celebrate the launch of their first Green Bond.

    As an investor and a developer, Icade is an integrated real estate player which designs innovative real estate products and services adapted to new urban lifestyles and habits. By placing corporate social responsibility and innovation at the core of its strategy, Icade is closely involved with stakeholders and users in the cities— local authorities and communities, companies and employees, institutions and associations… As a commercial and healthcare property investor (portfolio value of €9.9bn as of 06/30/17) and as a property developer (2016 economic revenues of €1,005m), Icade is able to reinvent the real estate business and foster the emergence of tomorrow’s greener, smarter and more responsible cities. Icade is a significant player in the Greater Paris area and major French cities. Icade is listed on Euronext Paris as a French Listed Real Estate Investment Company (SIIC). Its leading shareholder is the Caisse des dépôts Group.

    For more information: www.icade.fr/en/

    Paris
  • IPO Biom'up

     |  Paris

    9003a71b21e4-f653-416b-888e-676328dafc53

    IPO Biom'up

    Listing of Biom'up on Euronext

    Etienne Binant, Chief Executive, Biom'up, opens the trading day in Paris.

    Biom'up specializes in research, development and manufacturing of implantable and resorbable collagen-based medical devices for surgery and regenerative medicine. The group especially offers haemostatic products that help control bleeding during surgery (Hemoblast) and collagen membranes that prevent organ adherence during surgery (Cova).

     

    Paris
  • IPO Biom'up

     |  Paris

    9003a71b21e4-f653-416b-888e-676328dafc53

    IPO Biom'up

    Listing of Biom'up on Euronext

    Etienne Binant, Chief Executive, Biom'up, opens the trading day in Paris.

    Biom'up specializes in research, development and manufacturing of implantable and resorbable collagen-based medical devices for surgery and regenerative medicine. The group especially offers haemostatic products that help control bleeding during surgery (Hemoblast) and collagen membranes that prevent organ adherence during surgery (Cova).

     

    Paris
  • Transfer of M2i to Euronext Growth

     |  Paris

    899501f9c340-a82a-43c0-b140-b43de50444f7

    Transfer of M2i to Euronext Growth

    Transfer of M2i to Euronext Growth

    George Seban, CEO M2i, closes the European trading day in Paris

    M2i (Maison Internationale de l'Informatique) specializes in professional training services for the computer science, office automation, multimedia and management sectors. The group runs more than 2,000 internship programs in 35 centers in France.

    Paris
  • Transfer of M2i to Euronext Growth

     |  Paris

    899501f9c340-a82a-43c0-b140-b43de50444f7

    Transfer of M2i to Euronext Growth

    Transfer of M2i to Euronext Growth

    George Seban, CEO M2i, closes the European trading day in Paris

    M2i (Maison Internationale de l'Informatique) specializes in professional training services for the computer science, office automation, multimedia and management sectors. The group runs more than 2,000 internship programs in 35 centers in France.

    Paris
  • Pharmasimple

     |  Paris

    8977f1955414-e0ce-4e82-875a-bb6926c75739

    Pharmasimple

    Listing of Pharmasimple on Euronext Growth

    Michael Willems, CEO and Founder of Pharmasimple , opens the trading day in Paris.

    Pharmasimple specializes in the online sale of parapharmaceuticals. The company has 120,000 references (770 brands) of cosmetics and dermo-cosmetics, medical accessories and dietary supplements.The company has over 300,000 customers and nearly 120,000 orders per year.France accounts for 90% of net sales.

    Paris
  • Pharmasimple

     |  Paris

    8977f1955414-e0ce-4e82-875a-bb6926c75739

    Pharmasimple

    Listing of Pharmasimple on Euronext Growth

    Michael Willems, CEO and Founder of Pharmasimple , opens the trading day in Paris.

    Pharmasimple specializes in the online sale of parapharmaceuticals. The company has 120,000 references (770 brands) of cosmetics and dermo-cosmetics, medical accessories and dietary supplements.The company has over 300,000 customers and nearly 120,000 orders per year.France accounts for 90% of net sales.

    Paris
  • LiquidShare

     |  Paris

    89725905c543-e7bb-401f-a6b2-aabd7e431362

    LiquidShare

    LiquidShare, the European blockchain fintech for SME post trade, celebrates its launch together with its 8 shareholders and partners.

    LiquidShare, together with its shareholders BNP Paribas, CACEIS, Caisse des Dépôts, Euroclear, Euronext, S2iEM and Société Générale and with the support of Paris EUROPLACE, closes the trading day in Paris to celebrate the launch of this new European blockchain fintech dedicated to SME post trade. The core objective of this dynamic and innovative company is to improve SMEs' access to capital markets, enhancing the transparency and security of post-trading operations, using blockchain.

    Paris
  • LiquidShare

     |  Paris

    89725905c543-e7bb-401f-a6b2-aabd7e431362

    LiquidShare

    LiquidShare, the European blockchain fintech for SME post trade, celebrates its launch together with its 8 shareholders and partners.

    LiquidShare, together with its shareholders BNP Paribas, CACEIS, Caisse des Dépôts, Euroclear, Euronext, S2iEM and Société Générale and with the support of Paris EUROPLACE, closes the trading day in Paris to celebrate the launch of this new European blockchain fintech dedicated to SME post trade. The core objective of this dynamic and innovative company is to improve SMEs' access to capital markets, enhancing the transparency and security of post-trading operations, using blockchain.

    Paris
  • Groupe RATP Green Bond

     |  Paris

    89398bebe0cf-6aee-48ad-a74d-cd0208733d59

    Groupe RATP Green Bond

    Alain Le Duc, CFO of Groupe RATP, and Marie-Claude Dupuis,  Director of Strategy Innovation & Development, celebrate the launch of their first Green Bond.

    The RATP Group is the world's fifth largest public transport company, operating all types of collective mobility: bus, metro, trains and trams. Every day, the RATP Group manages more than 16 million trips around the world.
    Low-carbon and sustainable transport has a key role to play in facilitating a modal transportation shift, enabling the transition to a low carbon economy, to support future climate change mitigation efforts and to build the sustainable city.
    That's why RATP has set the objectives to reduce its greenhouse gases emissions (GHG) by 50% between 2015 and 2025 and to reduce energy consumption by 20% at the same period.
    The €500 million RATP Green Bond issuance, dedicated to low-carbon and sustainable transport, is an opportunity to emphasize the group’s strategy in terms of sustainability and climate change, and to diversify the RATP investor base, thanks to a reinforced dialogue with Socially Responsible Investors.

    Paris
  • Groupe RATP Green Bond

     |  Paris

    89398bebe0cf-6aee-48ad-a74d-cd0208733d59

    Groupe RATP Green Bond

    Alain Le Duc, CFO of Groupe RATP, and Marie-Claude Dupuis,  Director of Strategy Innovation & Development, celebrate the launch of their first Green Bond.

    The RATP Group is the world's fifth largest public transport company, operating all types of collective mobility: bus, metro, trains and trams. Every day, the RATP Group manages more than 16 million trips around the world.
    Low-carbon and sustainable transport has a key role to play in facilitating a modal transportation shift, enabling the transition to a low carbon economy, to support future climate change mitigation efforts and to build the sustainable city.
    That's why RATP has set the objectives to reduce its greenhouse gases emissions (GHG) by 50% between 2015 and 2025 and to reduce energy consumption by 20% at the same period.
    The €500 million RATP Green Bond issuance, dedicated to low-carbon and sustainable transport, is an opportunity to emphasize the group’s strategy in terms of sustainability and climate change, and to diversify the RATP investor base, thanks to a reinforced dialogue with Socially Responsible Investors.

    Paris
  • TURBOS LIFE

     |  Paris

    8928306c99fb-1088-401c-bc5f-ba3305c0ac45

    TURBOS LIFE

    Société Générale celebrates the listing of TURBOS LIFE

    Société Générale opens the trading day in Paris for the listing of Turbos Life.

    Turbos Life is a brand new range of structured products listed on Euronext Paris. These leveraged products are infinite Turbos whose knock-out don't lead to deactivation but only an adjustment in its caracteristics, the infinite rebirth of the Turbo.

    Paris
  • TURBOS LIFE

     |  Paris

    8928306c99fb-1088-401c-bc5f-ba3305c0ac45

    TURBOS LIFE

    Société Générale celebrates the listing of TURBOS LIFE

    Société Générale opens the trading day in Paris for the listing of Turbos Life.

    Turbos Life is a brand new range of structured products listed on Euronext Paris. These leveraged products are infinite Turbos whose knock-out don't lead to deactivation but only an adjustment in its caracteristics, the infinite rebirth of the Turbo.

    Paris
  • Carmila

     |  Paris

    8923ea253ba3-592e-403d-97ff-e9c09aacce31

    Carmila

    Listing of Carmila on Euronext

    Jacques Ehrmann, CEO of Carmila, opens the trading day in Paris.

    After the merger-absorption of Carmila in June 2017, Cardety changed its name to Carmila. The new group owns and manages business parks and shopping malls.

    Paris
  • Carmila

     |  Paris

    8923ea253ba3-592e-403d-97ff-e9c09aacce31

    Carmila

    Listing of Carmila on Euronext

    Jacques Ehrmann, CEO of Carmila, opens the trading day in Paris.

    After the merger-absorption of Carmila in June 2017, Cardety changed its name to Carmila. The new group owns and manages business parks and shopping malls.

    Paris
  • Candriam ETFs

     |  Paris

    891584b2f511-690c-43d4-9aee-9d37a8318890

    Candriam ETFs

    Candriam ETFs list on Euronext Paris and cross-list on Euronext Amsterdam

    Koen Van de Maele, Deputy Chief Investment Officer of Candriam, opens the trading day in Paris for the listing of their ESG and Smart Beta specialised ETFs on Euronext Paris and cross-listing at Euronext Amsterdam. Candriam Investors Group is a leading pan-European multi-specialist asset manager with a 20-year track record and a team of 500 experienced professionals, managing about €107.2 bn AuM at the end of March 2017.

    Paris
  • Candriam ETFs

     |  Paris

    891584b2f511-690c-43d4-9aee-9d37a8318890

    Candriam ETFs

    Candriam ETFs list on Euronext Paris and cross-list on Euronext Amsterdam

    Koen Van de Maele, Deputy Chief Investment Officer of Candriam, opens the trading day in Paris for the listing of their ESG and Smart Beta specialised ETFs on Euronext Paris and cross-listing at Euronext Amsterdam. Candriam Investors Group is a leading pan-European multi-specialist asset manager with a 20-year track record and a team of 500 experienced professionals, managing about €107.2 bn AuM at the end of March 2017.

    Paris
  • IPO Valbiotis

     |  Paris

    891485b586d9-de50-4853-9a27-f2783ee62f5c

    IPO Valbiotis

    Listing of Valbiotis on Euronext

    Sébastien Peltier, CEO of Valbiotis, opens the trading day in Paris.

    Valbiotis is a biopharmaceutical company specializing in the research and development of preventive and therapeutic products based on polymolecular complexes indicated at specific stages of progression of chronic metabolic pathologies such as type 2 diabetes, obesity, dyslipidemia or NASH (Non-Alcoholic Steatosis Hepatic).

    Paris